- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
BioForce Nanosciences, Inc., a wholly owned subsidiary of BioForce Nanosciences Holdings, Inc. (OTCBB:BFNH), announced today the receipt of the second year of funding under a National Institutes of Health (NIH) Small Business Innovation Research (SBIR) grant for nearly $200,000, furthering its Emerging Technologies program. This brings the total funding under the grant to $400,000. The funding will be used to construct and evaluate a nanobiosensor capable of detecting protein biomarkers from just a few cells. The proposed nanobiosensor, with the tradename Chip-on-a-Tip(TM), opens the door to fast and informative analysis of minute protein samples such as those studied in forensics or biopsy microsamples.
This SBIR Phase I grant work will progress through April 2008 and involve a feasibility study to construct and evaluate the Chip-on-a-Tip(TM) device. If successful, this device is anticipated to provide the means for early detection of cancer and other diseases with a significant reduction in patient discomfort.
Dr. Eric Henderson, BioForce's founder and CEO commented, "This concept creates a test so small that it can be brought directly to the sample origin, for example a cell, eliminating the difficulties associated with transporting extremely small quantities of sample extracts to a remote test site. The technology has the capacity to allow individuals to carry out personalized medicine at home." The research is made possible by BioForce's Nano eNabler(TM) benchtop molecular printer, which is capable of "printing" the extremely small tests on the nanobiosensor.
Dr. Saju Nettikadan, director of Emerging Technologies at BioForce said, "The NIH funding validates BioForce's belief that miniaturization of biological tests is a pathway to minimally invasive molecular diagnostics. BioForce's Chip-on-a-Tip(TM) project is just one element of our Emerging Technologies division."
About BioForce Nanosciences, Inc.
BioForce Nanosciences develops and commercializes nanotech tools and solutions for the life sciences. For more information, visit http://www.bioforcenano.com .
This news release contains forward-looking information that may be affected by certain risks and uncertainties, including those risks and uncertainties described in the Company's most recent filings with the Securities and Exchange Commission. The Company's actual results could differ materially from such forward-looking statements. We assume no duty to update these statements at any future date.
For more information, please click here
RedChip Companies Inc.
Robert Rehse, 1-800-REDCHIP (733-2447) ext 111
BioForce Nanosciences, Inc.
Deb Happe, 515-233-8333, Ext. 123
Director of Communications
Copyright © Business Wire 2007If you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
Chains of nanogold – forged with atomic precision September 23rd, 2016
Speedy bacteria detector could help prevent foodborne illnesses September 21st, 2016
Picosun patents ALD nanolaminate to prevent electronics from overheating September 28th, 2016
Fighting cancer with sticky nanoparticles September 27th, 2016
Bringing graphene speakers to the mobile market (video) September 12th, 2016
Novel nanoscale detection of real-time DNA amplification holds promise for diagnostics: Research team led by Nagoya University develop a label-free method for detecting DNA amplification in real time based on refractive index changes in diffracted light September 12th, 2016